Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IDXX

IDXX - IDEXX Laboratories Inc Stock Price, Fair Value and News

$687.62-7.13 (-1.03%)
Market Closed

37/100

IDXX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

37/100

IDXX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$555.08

Target 3M

$644.59

Target 6M

$598.79

IDXX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IDXX Price Action

Last 7 days

-1.3%

Last 30 days

0.0%

Last 90 days

9.4%

Trailing 12 Months

64.6%

IDXX RSI Chart

IDXX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IDXX Valuation

Market Cap

54.9B

Price/Earnings (Trailing)

53.44

Price/Sales (Trailing)

13.18

EV/EBITDA

38.96

Price/Free Cashflow

56.98

IDXX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$555.08

Target 3M

$644.59

Target 6M

$598.79

IDXX Fundamentals

IDXX Revenue

Revenue (TTM)

4.2B

Rev. Growth (Yr)

13.29%

Rev. Growth (Qtr)

-0.38%

IDXX Earnings

Earnings (TTM)

1.0B

Earnings Growth (Yr)

17.94%

Earnings Growth (Qtr)

-6.59%

IDXX Profitability

Operating Margin

62.60%

EBT Margin

30.56%

Return on Equity

65.81%

Return on Assets

30.34%

Free Cashflow Yield

1.75%

IDXX Investor Care

Buy Backs (1Y)

2.48%

Diluted EPS (TTM)

12.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20253.9B4.0B4.2B0
20243.7B3.8B3.8B3.9B
20233.4B3.5B3.6B3.7B
20223.3B3.3B3.3B3.4B
20212.9B3.0B3.1B3.2B
20202.5B2.5B2.6B2.7B
20192.3B2.3B2.4B2.4B
20182.0B2.1B2.2B2.2B
20171.8B1.9B1.9B2.0B
20161.6B1.7B1.7B1.8B
20151.5B1.5B1.6B1.6B
20141.4B1.4B1.5B1.5B
20131.3B1.3B1.3B1.4B
20121.2B1.3B1.3B1.3B
20111.1B1.2B1.2B1.2B
20100001.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About IDEXX Laboratories Inc

IDXX
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
 CEO
 WEBSITEidexx.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES11000

IDEXX Laboratories Inc Frequently Asked Questions

IDXX is the stock ticker symbol of IDEXX Laboratories Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of IDEXX Laboratories Inc is 54.91 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check IDXX's fair value in chart for subscribers.

The fair value guage provides a quick view whether IDXX is over valued or under valued. Whether IDEXX Laboratories Inc is cheap or expensive depends on the assumptions which impact IDEXX Laboratories Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IDXX.

As of Wed Jan 28 2026, IDXX's PE ratio (Price to Earnings) is 53.44 and Price to Sales (PS) ratio is 13.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IDXX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, IDEXX Laboratories Inc has provided 0.256 (multiply by 100 for percentage) rate of return.